Results 1 to 10 of about 10,112 (181)
Ocular myasthenia gravis management [PDF]
Frontiers in NeurologyOcular myasthenia gravis (OMG) has no agreed-upon diagnostic and management criteria, leading to misdiagnoses and often misguided treatments. The purpose of this minireview is to provide guidance to clinicians who encounter possible OMG patients. We cite
Mark J. Kupersmith +2 more
doaj +3 more sources
Delayed Diagnosis of Atypical Presentation of Myasthenia Gravis [PDF]
European Journal of Case Reports in Internal Medicine, 2017 Myasthenia gravis is an autoimmune disorder affecting the neuromuscular junction, resulting in muscle fatiguability and weakness. The pathological characteristics of the disorder include ocular weakness resulting in diplopia and/or ptosis.
Moneeb Sefeldawla Mustafa +3 more
doaj +4 more sources
New acute onset of ocular myasthenia gravis after COVID-19 vaccine: A case report [PDF]
Journal of Family Medicine and Primary Care, 2023 Reports have shown the association of coronavirus disease 2019 (COVID-19) with several neuromuscular disorders. Myasthenia gravis (MG) is an autoimmune disease in which antibodies bind to acetyl choline receptors in the postsynaptic membrane at the ...
Himani T. Chaturvedi +3 more
doaj +2 more sources
Add‐On Telitacicept Significantly Improves Outcome of Patients With Refractory Ocular Myasthenia Gravis a Real‐World Case Series [PDF]
Brain and BehaviorIntroduction Refractory ocular myasthenia gravis (MG) represents a significant therapeutic challenge, as conventional immunotherapies often prove ineffective.
Jing Lin +4 more
doaj +2 more sources
Outcomes of Treatment in Ocular Myasthenia Gravis Based on Minimal Manifestation: A Real-World Retrospective Cohort Study [PDF]
Clinical OphthalmologyParinee Kemchoknatee,1 Boonravee Santitamrongvtit,2 Thansit Srisombut3 1Department of Ophthalmology, Rajavithi Hospital, Rangsit University, Bangkok, Thailand; 2Department of Medicine, Phra Nang Klao Hospital, Nonthaburi, Thailand; 3Department of ...
Kemchoknatee P +2 more
doaj +2 more sources
Ocular myasthenia gravis: A review
Indian Journal of Ophthalmology, 2014 Myasthenia gravis (MG) is a disease that affects the neuro-muscular junction resulting in classical symptoms of variable muscle weakness and fatigability. It is called the great masquerader owing to its varied clinical presentations.
Akshay Gopinathan Nair +3 more
doaj +3 more sources
Frontiers in Pediatrics, 2022 Myasthenia gravis is an organ-specific autoimmune disease. Currently there is no universal guidelines for childhood-onset myasthenia gravis, therefore, treatment strategies are usually based on the guidelines from adult myasthenia gravis patients.
Lifen Yang +6 more
doaj +1 more source
American Journal of Ophthalmology Case Reports, 2023 Purpose: This is a case of myasthenic incomplete ophthalmoplegia mimicking a partial cranial nerve 3 palsy both subjectively and objectively improving after treatment with eculizumab.
Sara L. Weidmayer, Gary Gallagher
doaj +1 more source
Concentric Needle Jitter in 97 Myasthenia Gravis Patients
Frontiers in Neurology, 2020 Objectives: To estimate the jitter parameters (single-fiber electromyography) in myasthenia gravis patients mostly by electrical activation in Frontalis, Orbicularis Oculi, and Extensor Digitorum muscles using a concentric needle electrode.Methods ...
João Aris Kouyoumdjian +2 more
doaj +1 more source
Flow cytofluorimetric analysis of anti-LRP4 (LDL receptor-related protein 4) autoantibodies in Italian patients with Myasthenia gravis [PDF]
, 2015 Background: Myasthenia gravis (MG) is an autoimmune disease in which 90% of patients have autoanti-bodies against the muscle nicotinic acetylcholine receptor (AChR), while autoantibodies to muscle-specific tyrosine kinase (MuSK) have been detected in ...
Antonini, Giovanni +11 more
core +6 more sources